共 50 条
- [31] CCL5 mediates Target-Kinase independent resistance to FLT3 tyrosine kinase inhibitors in FLT3-ITD-positive AMLONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 143 - 143Waldeck, S.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, Germany German Canc Res Ctr, Freiburg, Germany Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, GermanyRassner, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, GermanyPhilipp, U.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, GermanyAndrieux, G.论文数: 0 引用数: 0 h-index: 0机构: Univ Freiburg, Inst Mol Med & Cell Res, Freiburg, Germany Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, GermanyKeye, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, GermanyWaterhouse, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, GermanyDuyster, J.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, Freiburg, Germany Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, Germanyvon Bubnoff, N.论文数: 0 引用数: 0 h-index: 0机构: Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, Germany German Canc Res Ctr, Freiburg, Germany Univ Klinikum Freiburg, Klin Innere Med Hamatol Onkol & Stammzelltranspla, German Canc Consortium DKTK 2, Freiburg, Germany
- [32] LAM-003, a new drug for treatment of tyrosine kinase inhibitor-resistant FLT3-ITD-positive AMLBLOOD ADVANCES, 2019, 3 (22) : 3661 - 3673Beeharry, Neil论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USALandrette, Sean论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USAGayle, Sophia论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USAHernandez, Marylens论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USAGrotzke, Jeff E.论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USAYoung, Peter R.论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USABeckett, Paul论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USAZhang, Xuan论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USACarter, Bing Z.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia, Houston, TX 77030 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USAAndreeff, Michael论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Leukemia & Stem Cell Transplantat & Cellular, Houston, TX 77030 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USAHalene, Stephanie论文数: 0 引用数: 0 h-index: 0机构: Yale Sch Med, Dept Hematol, New Haven, CT USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USAXu, Tian论文数: 0 引用数: 0 h-index: 0机构: Yale Sch Med, Howard Hughes Med Inst, Dept Genet, New Haven, CT USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USARothberg, Jonathan论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USALichenstein, Henri论文数: 0 引用数: 0 h-index: 0机构: AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA AI Therapeut, 530 Whitfield St, Guilford, CT 06437 USA
- [33] Inhibition of heme oxygenase 1 decreases proliferation and resensitizes TKI-resistant Flt3-ITD-positive AML cellsCANCER RESEARCH, 2015, 75Irwin, Mary E.论文数: 0 引用数: 0 h-index: 0机构: UT MD Anderson Canc Ctr, Houston, TX USA UT MD Anderson Canc Ctr, Houston, TX USAChandra, Joya论文数: 0 引用数: 0 h-index: 0机构: UT MD Anderson Canc Ctr, Houston, TX USA UT MD Anderson Canc Ctr, Houston, TX USA
- [34] Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AMLINVESTIGATIONAL NEW DRUGS, 2020, 38 (02) : 340 - 349Jeon, Jae Yoon论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAZhao, Qiuhong论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USABuelow, Daelynn R.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA论文数: 引用数: h-index:机构:Walker, Alison R.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAMims, Alice S.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAVasu, Sumithira论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USABehbehani, Gregory论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USABlachly, James论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA论文数: 引用数: h-index:机构:Klisovic, Rebecca B.论文数: 0 引用数: 0 h-index: 0机构: Emory Univ, Sch Med, Dept Hematol & Med Oncol, Winship Canc Inst, Atlanta, GA USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAByrd, John C.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USAGarzon, Ramiro论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USABaker, Sharyn D.论文数: 0 引用数: 0 h-index: 0机构: Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA Ohio State Univ, Dept Internal Med, Div Hematol, Columbus, OH 43210 USA Ohio State Univ, Comprehens Canc Ctr, Columbus, OH 43210 USA Ohio State Univ, Coll Pharm, Div Pharmaceut & Pharmaceut Chem, 500 W 12Th Ave, Columbus, OH 43210 USA论文数: 引用数: h-index:机构:
- [35] Preclinical activity and a pilot phase I study of pacritinib, an oral JAK2/FLT3 inhibitor, and chemotherapy in FLT3-ITD-positive AMLInvestigational New Drugs, 2020, 38 : 340 - 349Jae Yoon Jeon论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyQiuhong Zhao论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyDaelynn R. Buelow论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyMitch Phelps论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyAlison R. Walker论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyAlice S. Mims论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacySumithira Vasu论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyGregory Behbehani论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyJames Blachly论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyWilliam Blum论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyRebecca B. Klisovic论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyJohn C. Byrd论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyRamiro Garzon论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacySharyn D. Baker论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of PharmacyBhavana Bhatnagar论文数: 0 引用数: 0 h-index: 0机构: The Ohio State University,Division of Pharmaceutics and Pharmaceutical Chemistry, College of Pharmacy
- [36] Targeting the NRF2/HO-1 Antioxidant Pathway in FLT3-ITD-Positive AML Enhances Therapy EfficacyANTIOXIDANTS, 2022, 11 (04)Kannan, Sankaranarayan论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USAIrwin, Mary E.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USAHerbrich, Shelley M.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA Univ Texas MD Anderson UT Hlth, Grad Sch Biomed Sci, Houston, TX 77004 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USACheng, Tiewei论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USAPatterson, LaNisha L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USAAitken, Marisa J. L.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA Univ Texas MD Anderson UT Hlth, Grad Sch Biomed Sci, Houston, TX 77004 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USABhalla, Kapil论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USAYou, M. James论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Hematopathol, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USAKonopleva, Marina论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Leukemia, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USAZweidler-McKay, Patrick A.论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA Univ Texas MD Anderson UT Hlth, Grad Sch Biomed Sci, Houston, TX 77004 USA ImmunoGen, Waltham, MA 02451 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USAChandra, Joya论文数: 0 引用数: 0 h-index: 0机构: Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA Univ Texas MD Anderson UT Hlth, Grad Sch Biomed Sci, Houston, TX 77004 USA Univ Texas MD Anderson Canc Ctr, Epigenet & Mol Carcinogenesis, Houston, TX 77030 USA Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, Houston, TX 77030 USA
- [37] Role of allogeneic stem cell transplantation in FLT3/ITD-positive AMLBLOOD, 2006, 108 (01) : 400 - 400Meshinchi, Sohell论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USAArceci, Robert J.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USASanders, Jean E.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USASmith, Franklin O.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USAWoods, William B.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USARadich, Jerald R.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USAAlonzo, Todd A.论文数: 0 引用数: 0 h-index: 0机构: Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA Fred Hutchinson Canc Res Ctr, Div Clin Res, Seattle, WA 98103 USA
- [38] REACTIVE OXYGEN SPECIES (ROS) MODULATES SENSITIVITY TO FLT3-TYROSINE KINASE INHIBITORS IN MURINE AND HUMAN FLT3-ITD POSITIVE AML CELL LINESHAEMATOLOGICA, 2016, 101 : 362 - 363Mueller, C.论文数: 0 引用数: 0 h-index: 0机构: Univ Clin Magdeburg, Dept Hematol & Oncol, Magdeburg, Germany Univ Clin Magdeburg, Dept Hematol & Oncol, Magdeburg, GermanySimeoni, L.论文数: 0 引用数: 0 h-index: 0机构: Univ Clin Magdeburg, Inst Mol & Clin Immunol, Magdeburg, Germany Univ Clin Magdeburg, Dept Hematol & Oncol, Magdeburg, GermanyHeidel, F.论文数: 0 引用数: 0 h-index: 0机构: Univ Clin Magdeburg, Dept Hematol & Oncol, Magdeburg, Germany Univ Clin Magdeburg, Dept Hematol & Oncol, Magdeburg, GermanySchraven, B.论文数: 0 引用数: 0 h-index: 0机构: Univ Clin Magdeburg, Inst Mol & Clin Immunol, Magdeburg, Germany Univ Clin Magdeburg, Dept Hematol & Oncol, Magdeburg, GermanyFischer, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Clin Magdeburg, Dept Hematol & Oncol, Magdeburg, Germany Univ Clin Magdeburg, Dept Hematol & Oncol, Magdeburg, Germany
- [39] TARGETING THE DBC1-SIRT1-P53 AXIS IS A PROMISING THERAPEUTIC STRATEGY IN FLT3-ITD-POSITIVE AMLHAEMATOLOGICA, 2013, 98 : 401 - 401Sasca, D.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Med Dept 3, Mainz, Germany Univ Med Ctr, Med Dept 3, Mainz, GermanyHaehnel, P.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Med Dept 3, Mainz, Germany Univ Med Ctr, Med Dept 3, Mainz, GermanyAl-Khawaja, K.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Med Dept 3, Mainz, Germany Univ Med Ctr, Med Dept 3, Mainz, GermanyBullinger, L.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Med Dept 3, Ulm, Germany Univ Med Ctr, Med Dept 3, Mainz, GermanyTheobald, M.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Med Dept 3, Mainz, Germany Univ Med Ctr, Med Dept 3, Mainz, GermanyKindler, T.论文数: 0 引用数: 0 h-index: 0机构: Univ Med Ctr, Med Dept 3, Mainz, Germany Univ Med Ctr, Med Dept 3, Mainz, Germany
- [40] Discontinuation of sorafenib can lead to the emergence of FLT3-ITD-positive acute myeloid leukemiaJOURNAL OF ONCOLOGY PHARMACY PRACTICE, 2019, 25 (08) : 2010 - 2015Kakiuchi, Seiji论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan Yodogawa Christians Hosp, Dept Hematol, Osaka, Osaka, Japan Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, JapanYakushijin, Kimikazu论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, JapanSakai, Rina论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, JapanKawaguchi, Koji论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, JapanHigashime, Ako论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:Nagao, Shigeki论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan Natl Def Med Coll Hosp, Dept Internal Med, Div Hematol, Tokorozawa, Saitama, Japan Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, JapanRikitake, Junpei论文数: 0 引用数: 0 h-index: 0机构: Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan Yodogawa Christians Hosp, Dept Hematol, Osaka, Osaka, Japan Kobe Univ Hosp, Div Med Oncol & Hematol, Kobe, Hyogo, Japan论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构:论文数: 引用数: h-index:机构: